OLGA ELDRIDGE: Open Payments
NPI 1750121307 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 95 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $555 · 2025 $1,644
Food & beverage: $1,644
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 27 | $329 |
| Neurocrine BioSciences, Inc. | 13 | $307 |
| Otsuka America Pharmaceutical, Inc. | 15 | $236 |
| Alkermes, Inc. | 10 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $160 |
| Janssen Pharmaceuticals, Inc | 5 | $103 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 4 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Lundbeck LLC | 3 | $48 |
Products named: COBENFY, INGREZZA, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, Auvelity, UZEDY.
Industry payments across MO — which companies pay providers there.
